Journal List > Tuberc Respir Dis > v.60(1) > 1000911

TOOLS
Kim: Pharmacology in Airway Diseases
Review
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2006; 60(1): 21-37.

Published online: 31 January 2006

DOI: https://doi.org/10.4046/trd.2006.60.1.21

Pharmacology in Airway Diseases

Kwan Hyoung Kim

Department of Internal Medicine, Medical College, The Catholic University of Korea, Korea.

Address for correspondence: Kwan Hyoung Kim, M.D., Department of Internal Medicine, Medical College, The Catholic University of Korea. Phone: 82-31-820-3000, Fax: 82-31-847-2719, kwan-kim@catholic.ac.kr

Copyright © 2006 The Korean Academy of Tuberculosis and Respiratory Diseases

References

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995. 152:S77–S121.
2. Barnes PJ, Belvisi MG, Mak JC, Haddad EB, O'Connor B. Tiotropiurn bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci. 1995. 56:853–859.
3. Casaburi R, Mahler DA, Jones PW, Wanner A, San Pedro G, ZuWallack RL, Menjoge SS, Serby CW, Witek TJ. A long-term evaluation of once daily inhaled tiotropium in chronic obstructive pulmonary disease. Fur Respir J. 2002. 19:217–224.
4. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med. 2003. 54:113–129.
5. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J. 1994. 7(3):579–591.
6. Riccioni G, Di Ilio C, D'Orazio N. Review: Pharmacological Treatment of Airway Remodeling: Inhaled Corticosteroids or Antileukotrienes? Ann Clin & Lab Sci. 2004. 34(2):138–142.
7. Sutherland ER, Reuben M, Cherniack RM. current concepts Management of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004. 350:2689–2697.
8. Barnes PJ. Theophylline New Perspectives for an Old Drug. Am J Resp Crit Care Med. 2003. 167:813–818.
9. Vignola AM. PDE4 inhibitors in COPDF a more selective approach to treatment. Resp Me. 2004. 98:495–503.
10. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. New Engl J Med. 2000. 343:1064–1069.
11. Barnes PJ. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990. 141:S70–S76.
12. Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin munol. 1998. 102:531–533.
13. Barnes PJ. Inhaled corticosteroids are not helpful in chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2000. 161:342–344.
14. Barnes PJ. Scientific rationale for combination inhalers with a long-acting β2agonists and corticosteroids. Eur Respir J. 2002. 19:182–191.
15. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J. 1998. 12:221–234.
16. Bergmann M, Barnes PJ, Newton R. Molecular regulation of granulocyte macrophage colony stimulating factor in human lung epithelial cells by interleukin (IL) 1/3, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanisms. Am J Respir Cell Mol Biol. 2000. 22:582–559.
17. Webster JC, Jewell CM, Cidlowski JA, Hu JM, Munck A. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol. 1998. 65:91–99.
18. Barnes N, Wei LX, Reiss TF, Leff JA, Shino S, Yu C, Edelman JM. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Respir Med. 2001. 95:379–386.
19. Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. J Allergy Clin Immunol. 1999. 103:1075–1080.
20. Dahlen S-E, Malmstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. Am J Respir Crit Care Med. 2002. 165:914.
21. Billington CK, Joseph SK, Swan C, Scott MG, Jobson TM, Hall IP. Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition. Am J Physiol. 1999. 276:L412–L419.
22. Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb IgE mAb, in birch-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2000. 106:253–259.
23. Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, Van Uden J, MartinOrozco E, Gelfand EW, Raz E. Immunostimulatory DNA sequences inhibit IL hyperresponsiveness in mice. J Immunol. 1998. 161:7054–7062.
24. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and shin test reactivity to allergens. New Eng J Med. 1989. 320:271–277.
TOOLS
Similar articles